CDK12/13 inhibition in ovarian cancer cell lines

被引：0
|
作者：
Fiegl, H. [1 ]
Hovdar, L. [1 ]
Handle, F. [2 ]
Santer, F. [3 ]
Tsibulak, I [1 ]
Wieser, V [1 ]
Ausserlechner, M. J. [4 ]
Schnaiter, S. [5 ]
Zeimet, A. G. [1 ]
Marth, C. [1 ]
机构：
[1] Med Univ Innsbruck, Dept Obstet & Gynecol, Innsbruck, Austria
[2] Med Univ Innsbruck, Inst Pathol Neuropathol & Mol Pathol, Innsbruck, Austria
[3] Med Univ Innsbruck, Dept Urol, Innsbruck, Austria
[4] Med Univ Innsbruck, Dept Pediat 1, Innsbruck, Austria
[5] Med Univ Innsbruck, Inst Human Genet, Innsbruck, Austria
来源：
GEBURTSHILFE UND FRAUENHEILKUNDE | 2023年 / 83卷 / 04期
关键词：
REPAIR;
D O I：
10.1055/s-0043-1766400
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
009
引用
收藏
页码：5 / 5
页数：1
相关论文
共 50 条
  • [1] Effects of CDK12/13 Inhibition in Patients with Ovarian Cancer
    Hovdar, L.
    Roessler, J.
    Hechenberger, P.
    Rainer, S.
    Ausserlechner, K.
    Greiderer-Kleinlercher, B.
    Ausserlechner, M.
    Marth, C.
    Zeimet, A. G.
    Fiegl, H.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2021, 81 (06) : E25 - E25
  • [2] Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13
    Zeng, Mei
    Kwiatkowski, Nicholas P.
    Zhang, Tinghu
    Nabet, Behnam
    Xu, Mousheng
    Liang, Yanke
    Quan, Chunshan
    Wang, Jinhua
    Hao, Mingfeng
    Palakurthi, Sangeetha
    Zhou, Shan
    Zeng, Qing
    Kirschmeier, Paul T.
    Meghani, Khyati
    Leggett, Alan L.
    Qi, Jun
    Shapiro, Geoffrey I.
    Liu, Joyce F.
    Matulonis, Ursula A.
    Lin, Charles Y.
    Konstantinopoulos, Panagiotis A.
    Gray, Nathanael S.
    ELIFE, 2018, 7
  • [3] Dual Inhibition of CDK12/CDK13 Targets Both Tumor and Immune Cells in Ovarian Cancer
    Cheng, Lin
    Zhou, Shichao
    Zhou, Shaoqing
    Shi, Kaixuan
    Cheng, Yan
    Cai, Mei-Chun
    Ye, Kaiyan
    Lin, Lifeng
    Zhang, Zhenfeng
    Jia, Chenqiang
    Xiang, Huaijiang
    Zang, Jingyu
    Zhang, Meiying
    Yin, Xia
    Li, Ying
    Di, Wen
    Zhuang, Guanglei
    Tan, Li
    CANCER RESEARCH, 2022, 82 (19) : 3588 - 3602
  • [4] Targeting the transcriptional kinases CDK12 and CDK13 in breast and ovarian cancer
    Hamman, Kristin
    Bradley, Michael
    Marineau, Jason
    Choi, Yoon
    Malojcic, Goran
    Orlando, David
    Ren, Yixuan
    Ke, Nan
    Hu, Shanhu
    Olson, Eric
    Fritz, Christian
    Roberts, Christopher
    FASEB JOURNAL, 2017, 31
  • [5] Targeting the transcriptional kinases CDK12 and CDK13 in breast and ovarian cancer
    Bradley, Michael
    Marineau, Jason
    Choi, Yoon
    Hamman, Kristin
    Malojcic, Goran
    Orlando, David
    Ren, Yixuan
    Ke, Nan
    Hu, Shanhu
    Olson, Eric
    Fritz, Christian
    Roberts, Christopher
    CANCER RESEARCH, 2017, 77
  • [6] Therapeutic potential of dual CDK12 and 13 inhibition in colorectal cancer
    Altunel, Erdem
    Zokaasadi, Mohammad
    Somarelli, Jason A.
    McCall, Shannon J.
    Gultawatvichai, Patan
    Whalen, Giles Francis
    Pitarresi, Jason
    Hsu, David S.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [7] The promise and current status of CDK12/13 inhibition for the treatment of cancer
    Tadesse, Solomon
    Duckett, Derek R.
    Monastyrskyi, Andrii
    FUTURE MEDICINAL CHEMISTRY, 2021, 13 (02) : 117 - 141
  • [8] Dual inhibition of CDK12 and CDK13 uncovers actionable vulnerabilities in patient-derived ovarian cancer organoids
    Cesari, Eleonora
    Ciucci, Alessandra
    Pieraccioli, Marco
    Caggiano, Cinzia
    Nero, Camilla
    Bonvissuto, Davide
    Sillano, Francesca
    Buttarelli, Marianna
    Piermattei, Alessia
    Loverro, Matteo
    Camarda, Floriana
    Greco, Viviana
    De Bonis, Maria
    Minucci, Angelo
    Gallo, Daniela
    Urbani, Andrea
    Vizzielli, Giuseppe
    Scambia, Giovanni
    Sette, Claudio
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2023, 42 (01)
  • [9] Dual inhibition of CDK12 and CDK13 uncovers actionable vulnerabilities in patient-derived ovarian cancer organoids
    Eleonora Cesari
    Alessandra Ciucci
    Marco Pieraccioli
    Cinzia Caggiano
    Camilla Nero
    Davide Bonvissuto
    Francesca Sillano
    Marianna Buttarelli
    Alessia Piermattei
    Matteo Loverro
    Floriana Camarda
    Viviana Greco
    Maria De Bonis
    Angelo Minucci
    Daniela Gallo
    Andrea Urbani
    Giuseppe Vizzielli
    Giovanni Scambia
    Claudio Sette
    Journal of Experimental & Clinical Cancer Research, 42
  • [10] Characterisation of pharmacological phenotypes of CDK12/ 13 inhibition
    Jacob, K.
    Thomann, A.
    Weber, C.
    Gudennann, T.
    Peters, A.
    Zierfer, S.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2024, 397 : S70 - S70
12345